Expanded Safety and Immunogenicity of a Bivalent, Oral, Attenuated Cholera Vaccine, CVD 103-HgR Plus CVD 111, in United States Military Personnel Stationed in Panama

To provide optimum protection against classical and El Tor biotypes of Vibrio cholerae O1, a single-dose, oral cholera vaccine was developed by combining two live, attenuated vaccine strains, CVD 103-HgR (classical, Inaba) and CVD 111 (El Tor, Ogawa). The vaccines were formulated in a double-chamber...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Taylor, David N., Sanchez, José L., Castro, José M., Lebron, Carlos, Parrado, Carlos M., Johnson, David E., Tacket, Carol O., Losonsky, Genevieve A., Wasserman, Steven S., Levine, Myron M., Cryz, Stanley J.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 1999
Matèries:
Microbial Immunity and Vaccines
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC96565/
https://ncbi.nlm.nih.gov/pubmed/10085055
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars